Original release date: January 10, 2022
Access to this course expires on: November 12, 2024 at 11:59 PM Pacific Time
As a major clinical subspecialty, diagnostic gynecological pathology involves a large number of disease entities and often complex histological variants. Recent developments, particularly molecular genetic discoveries, have introduced new and reclassified entities as well as refined diagnostic criteria for many existing disease processes, calling for knowledge update for practicing pathologists. A comprehensive review course is essential and highly desirable. This unique course offers an engaged learning experience with world-class faculty delegated from the International Society of Gynecological Pathologists (ISGyP). While providing comprehensive coverage, the course emphasizes knowledge gains in morphologic recognition, using ancillary immunohistochemistry and molecular genetic studies in the most challenging areas, particularly new disease classifications/diagnostic criteria.
Practicing academic and community pathologists, and pathologists-in-training
Upon completion of this educational activity, learners will be able to:
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the United States and Canadian Academy of Pathology and the International Society of Gynecological Pathologists. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 17.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. USCAP has reviewed the disclosures and mitigated all relevant financial relationships.
The following faculty reported no relevant financial relationships: Pei Hui, MD, PhD, Joseph Rabban, MD, MPH, Esther Oliva, MD, Robert Soslow, MD, W Glenn McCluggage, MD, FRCPath, C. Blake Gilks, MD
The following IM Coordinator who planned and reviewed content for this activity reported no relevant financial relationships: Oluwole Fadare, MD
USCAP staff associated with the development of content for this activity reported no relevant financial relationships.
To earn CME credit, all learners must complete the evaluation. View and print your certificate by clicking here.
Buy the entire course and get a great discount! Not A Member? Click Here